BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6519356)

  • 41. [Determination of antibodies against nicotinic acetylcholine receptor: clinico-immunological correlations in 30 patients with myasthenia gravis].
    De Crousaz G; Fulpius B; Monnier V; Regli F
    Schweiz Med Wochenschr; 1978 Apr; 108(16):602-7. PubMed ID: 644277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association of pauciarticular juvenile arthritis and myasthenia gravis.
    Glass JB; Sher PK; Lennon VA; Regelmann WE
    Am J Dis Child; 1991 Oct; 145(10):1176-80. PubMed ID: 1928013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
    Chen Y; Wang W; Wei D; Yang L
    Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients.
    Szobor A
    Acta Med Hung; 1989; 46(1):13-21. PubMed ID: 2771581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
    Wu X; Tüzün E
    Med Hypotheses; 2017 Feb; 99():26-28. PubMed ID: 28110692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Histocompatibility antigens in childhood myasthenia].
    Uhrynowska M
    Neurol Neurochir Pol; 1987; 21(2):119-24. PubMed ID: 3477704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):338-40. PubMed ID: 6402089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.
    Evoli A; Alboini PE; Iorio R; Damato V; Bartoccioni E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):761-763. PubMed ID: 28601810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ocular signs and symptoms of myasthenia gravis.
    Oosterhuis HJ
    Doc Ophthalmol; 1982 Jan; 52(3-4):363-78. PubMed ID: 7067604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New treatment approaches to myasthenia gravis.
    Havard CW; Fonseca V
    Drugs; 1990 Jan; 39(1):66-73. PubMed ID: 2178913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
    J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis.
    Dawkins RL; Christiansen FT; Garlepp MJ
    Ann N Y Acad Sci; 1981; 377():372-84. PubMed ID: 6951482
    [No Abstract]   [Full Text] [Related]  

  • 55. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
    Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
    Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.
    Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1246-52. PubMed ID: 4087000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contemporary management of myasthenia gravis: the clinical role of thymectomy.
    Faulkner SL; Ehyai A; Fisher RD; Fenichel GM; Bender HW
    Ann Thorac Surg; 1977 Apr; 23(4):348-52. PubMed ID: 849047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Childhood onset myasthenia gravis.
    Raksadawan N; Kankirawatana P; Balankura K; Prateepratana P; Sangruchi T; Atchaneeyasakul LO
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S769-77. PubMed ID: 12403259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.